
    
      This is a multicenter prospective trial. Enrollment will continue until 150 patients with
      chronic obstructive pulmonary disease and 50 patients with severe asthma have been entered
      into this trial and have completed bronchoscopic evaluation. In this trial, the following
      parameters are to be evaluated:

        -  Blood eosinophils (absolute and relative)

        -  FeNO

        -  Eosinophils in bronchoalveolar lavage

        -  Tissue eosinophilia (protected specimen brush sampling, endobronchial biopsy)
    
  